Get the Stockscreener App
1.86
1.64%
0.03
Pre-market:
1.92
0.06
+3.23%
Biomea Fusion Inc stock is traded at $1.86, with a volume of 342.33K.
It is up +1.64% in the last 24 hours and up +1.64% over the past month.
Biomea Fusion Inc is a clinical-stage diabetes and obesity medicines company focused on the discovery and development of oral covalent small-molecule drugs to treat patients with metabolic diseases. The company uses its proprietary FUSION System discovery platform to develop a pipeline of novel small-molecule product candidates. Its principal clinical program's drug candidate, icovamenib, is being developed as an orally bioavailable, selective covalent inhibitor of menin in two clinical and multiple preclinical studies, investigating icovamenib's potential in type 1 and type 2 diabetes, as well as its impact in obesity. The company is also developing BMF-650, an investigational, oral small-molecule GLP-1 RA, which has the potential to be a therapeutic option for diabetes and obesity.
See More
Previous Close:
$1.83
Open:
$1.83
24h Volume:
342.33K
Relative Volume:
0.15
Market Cap:
$110.69M
Revenue:
-
Net Income/Loss:
$-144.01M
P/E Ratio:
-0.4638
EPS:
-4.01
Net Cash Flow:
$-113.02M
1W Performance:
+4.49%
1M Performance:
+1.64%
6M Performance:
-33.57%
1Y Performance:
-76.28%
1-Day Range:
$1.82
$1.88
1-Week Range:
$1.72
$1.95
52-Week Range:
$1.2905
$13.07
Biomea Fusion Inc Stock (BMEA) Company Profile
Name
Biomea Fusion Inc
Sector
Industry
Phone
(650) 980-9099
Address
1599 INDUSTRIAL ROAD, SAN CARLOS
Compare BMEA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BMEA
Biomea Fusion Inc
|
1.86 | 108.90M | 0 | -144.01M | -113.02M | -4.01 |
|
VRTX
Vertex Pharmaceuticals Inc
|
389.08 | 99.27B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
586.96 | 62.28B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.18 | 59.14B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
707.96 | 43.34B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
300.14 | 36.72B | 3.81B | -644.79M | -669.77M | -6.24 |
Biomea Fusion Inc Stock (BMEA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-03-25 | Resumed | Piper Sandler | Overweight |
| Oct-09-24 | Initiated | Edward Jones | Buy |
| Sep-27-24 | Upgrade | Rodman & Renshaw | Neutral → Buy |
| Sep-27-24 | Upgrade | Truist | Hold → Buy |
| Aug-29-24 | Initiated | CapitalOne | Overweight |
| Jun-11-24 | Downgrade | Truist | Buy → Hold |
| Jun-07-24 | Downgrade | Barclays | Overweight → Equal Weight |
| Apr-02-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Feb-06-24 | Initiated | Truist | Buy |
| Jul-27-23 | Initiated | Scotiabank | Sector Outperform |
| Jun-26-23 | Downgrade | Jefferies | Buy → Hold |
| May-12-23 | Initiated | Barclays | Overweight |
| Mar-29-23 | Reiterated | Oppenheimer | Outperform |
| Mar-28-23 | Reiterated | H.C. Wainwright | Buy |
| Feb-24-23 | Initiated | Citigroup | Buy |
| Jun-02-22 | Resumed | H.C. Wainwright | Buy |
| Jan-12-22 | Initiated | H.C. Wainwright | Buy |
| Dec-17-21 | Initiated | Oppenheimer | Outperform |
| May-11-21 | Initiated | JP Morgan | Overweight |
| May-11-21 | Initiated | Jefferies | Buy |
| May-11-21 | Initiated | Piper Sandler | Overweight |
View All
Biomea Fusion Inc Stock (BMEA) Latest News
What MACD and RSI say about Biomea Fusion Inc.2025 Investor Takeaways & Daily Entry Point Trade Alerts - Newser
Advanced analytics toolkit walkthrough for Biomea Fusion Inc.M&A Rumor & Growth Oriented Trade Recommendations - Newser
What to do if you’re stuck in Biomea Fusion Inc.Portfolio Risk Summary & Real-Time Market Trend Scan - Newser
How to recover losses in Biomea Fusion Inc. stock2025 Bull vs Bear & Smart Money Movement Alerts - Newser
What MACD signals say about Biomea Fusion Inc.Volume Spike & Community Trade Idea Sharing - Newser
How to use Fibonacci retracement on Biomea Fusion Inc.July 2025 Sector Moves & Short-Term Swing Trade Alerts - Newser
What does recent volatility data suggest for Biomea Fusion Inc.2025 Momentum Check & Safe Capital Growth Tips - Newser
Published on: 2025-08-27 13:55:18 - Newser
Why Biomea Fusion Inc. stock attracts strong analyst attentionEarnings Overview Report & Weekly Watchlist of Top Performers - Newser
Real time alert setup for Biomea Fusion Inc. performance2025 Winners & Losers & Fast Entry High Yield Tips - Newser
What moving averages say about Biomea Fusion Inc.Share Buyback & Low Drawdown Momentum Ideas - Newser
Volatility clustering patterns for Biomea Fusion Inc.July 2025 Catalysts & Risk Adjusted Buy/Sell Alerts - Newser
Is Biomea Fusion Inc. stock ready for a breakout2025 Historical Comparison & Free Expert Approved Momentum Trade Ideas - Newser
Predicting Biomea Fusion Inc. trend using moving averagesJuly 2025 Technicals & Daily Entry Point Alerts - Newser
Will Biomea Fusion Inc. stock recover after recent drop2025 Macro Impact & Low Drawdown Investment Strategies - Newser
How to monitor Biomea Fusion Inc. with trend dashboardsPortfolio Profit Report & Short-Term Trading Opportunity Alerts - Newser
How to escape a deep drawdown in Biomea Fusion Inc.Bond Market & Long-Term Safe Investment Plans - Newser
Published on: 2025-08-26 15:11:05 - Newser
Intraday pattern recognizer results for Biomea Fusion Inc.Long Setup & Fast Entry and Exit Trade Plans - Newser
Sector ETF performance correlation with Biomea Fusion Inc.Earnings Recap Report & Fast Entry Momentum Alerts - Newser
Measuring Biomea Fusion Inc.’s beta against major indicesQuarterly Profit Review & Safe Entry Trade Reports - Newser
Using R and stats models for Biomea Fusion Inc. forecasting2025 Support & Resistance & Technical Confirmation Trade Alerts - Newser
Can Biomea Fusion Inc. reach resistance levels soonJuly 2025 Analyst Calls & Technical Pattern Based Buy Signals - theviewers.co.kr
Will Biomea Fusion Inc. outperform during market ralliesWeekly Trend Report & Verified Stock Trade Ideas - theviewers.co.kr
Can Biomea Fusion Inc. outperform under higher oil pricesWeekly Profit Recap & Daily Profit Focused Stock Screening - theviewers.co.kr
Is Biomea Fusion Inc. in a bullish channelPortfolio Risk Report & Pattern Based Trade Signal System - theviewers.co.kr
Will Biomea Fusion Inc. benefit from sector rotation2025 Biggest Moves & AI Forecast Swing Trade Picks - theviewers.co.kr
Quant Models Detect Momentum Reversal in Biomea Fusion Inc.2025 Market Sentiment & Fast Gain Swing Alerts - beatles.ru
Is Biomea Fusion Inc. trading at a discountJuly 2025 Action & Weekly Setup with ROI Potential - theviewers.co.kr
Real time social sentiment graph for Biomea Fusion Inc.Market Performance Recap & Expert Verified Movement Alerts - Newser
Is a relief rally coming for Biomea Fusion Inc. holdersQuarterly Investment Review & Fast Moving Trade Plans - Newser
Will Biomea Fusion Inc. stock hit new highs in YEARTrend Reversal & Growth-Oriented Investment Plans - newsimpact.co.kr
Fibonacci Levels Suggest Recovery for Biomea Fusion Inc.July 2025 Catalysts & High Yield Equity Trading Tips - beatles.ru
Blue Owl Capital Holdings LP Acquires 3,800,000 Shares in Biomea Fusion Inc: A Strategic Investment in the Biotechnology Sector - AInvest
Blue Owl Capital Holdings LP Acquires 3,800,000 Shares in Biomea Fusion Inc - GuruFocus
Quantitative breakdown of Biomea Fusion Inc. recent move2025 Geopolitical Influence & AI Enhanced Trading Signals - Newser
Certain Stock Options of Biomea Fusion, Inc. are subject to a Lock-Up Agreement Ending on 17-AUG-2025. - MarketScreener
Certain Common Stock of Biomea Fusion, Inc. are subject to a Lock-Up Agreement Ending on 17-AUG-2025. - MarketScreener
What makes Biomea Fusion Inc. stock price move sharplyWeekly Stock Report & Low Drawdown Investment Ideas - thegnnews.com
Biomea Fusion Faces Big Swings While Chasing Diabetes Breakthroughs - Finimize
Published on: 2025-08-16 07:07:16 - Newser
Biomea Fusion Inc Stock (BMEA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.98%
8.06%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):